Form 4 for AVTX Avalo Therapeutics, Inc.
Accepted 2023-06-13 00:00:00 ET · period of report 2023-06-09 · accession 0001628280-23-021962 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-13 | 2023-06-09 | AVTX | Sullivan Christopher Ryan | CFO | P - Purchase | $3.42 | +511 | 1,262 | +68% | +$1,748 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-09 | P | A | 511 | $3.42 | 1,262 | D | — | — | (F1) These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan. |